著者名,タイトル,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Ichihara E,Phase II trial of gefitinib in combination with bevacizumab as first‐line therapy for advanced non‐small‐cell lung cancer with activating EGFR gene mutations: The Okayama Lung Cancer Study Group trial 1001. J Thorac Oncol. International Association for the Study of,Lung Cancer,,,2015,10,,486,https://cir.nii.ac.jp/crid/1370857593718030596,